Research Progress of Shenlingbaizhu Powder in the Treatment of Malignant Tumor

Author:

Qing Lingling,Si Hailong,Zhao Xin,Cao Yixuan

Abstract

Traditional Chinese medicine considers that the deficiency of healthy qi and the disequilibrium of spleen and stomach are one of the basic pathogenesis of malignant tumor. Shenlingbaizhu Powder, as one of the classic representative prescriptions of invigorating spleen and invigorating qi, is widely used in the clinical treatment of malignant tumor. There are many literature reports on the mechanism of addition and reduction of Shenlingbaizhu powder in the treatment of malignant tumor. This article mainly reviews the research progress of Shenlingbaizhu powder in the treatment of malignant tumors from two aspects of clinical and experimental studies, in order to provide references for the clinical application of traditional Chinese medicine in the treatment of tumor and the development of new anticancer drugs.

Publisher

Century Science Publishing Co

Reference21 articles.

1. Song Jun, Wang Yanjie, Guo Jun-Fu, et al. Effect of serum containing Shenling Baizhu Powder on Toll Receptor-4 expression in lipopolysaccharids-induced SPCA1 cells [J]. Inner Mongolia Traditional Chinese Medicine, 2017, 36(19):119-121.

2. PENG Ying. Study on synergistic apoptosis-promoting effect of Shenling Baizhu Powder on H (22) liver cancer transplant tumor chemotherapy model mice [D]. Xiamen University, 2017.

3. Lai Y W. Effects of added flavor of Shenling Baizhu Powder on VEGF and mTOR pathway related proteins in bone cancer pain mice [D]. Guangxi University of Traditional Chinese Medicine, 2019.

4. Zou Huanqiu. Effects of flavorings of Shenling Baizhu Powder on AKT and P70S6 in bone cancer pain mice [D]. Guangxi University of Traditional Chinese Medicine, 2019.

5. Lv Y, Yang Y, Chen Y, et al. Structural characterization and immunomodulatory activity of a watersoluble polysaccharide from Poria cocos[J]. Int J Biol Macromol, 2, 024, 261(Pt 2):129878.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3